Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors

Details Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors

2005-07-19

2005-07-19

McKenzie, Thomas C. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C514S086000, C514S087000, C514S089000, C514S092000, C514S094000, C514S095000, C514S099000, C514S110000, C514S114000, C514S118000, C514S120000, C514S124000, C514S125000, C514S134000, C514S135000, C514S137000, C514S138000, C514S141000, C544S243000, C544S337000, C546S021000, C548S111000, C549S006000, C549S216000, C558S081000, C558S083000, C562S008000, C562S011000, C562S015000, C562S016000, C562S023000, C562S024000, C562S025000, C564S013000

Reexamination Certificate

active

06919322

ABSTRACT:
Novel FBPase inhibitors of the formula Iare useful in the treatment of diabetes and other conditions associated with elevated blood glucose.

REFERENCES:
patent: 3524846 (1970-08-01), Moffat et al.
patent: 4640701 (1987-02-01), Diel et al.
patent: 4968790 (1990-11-01), DeVries et al.
patent: 5045557 (1991-09-01), Buss et al.
patent: 5157027 (1992-10-01), Biller et al.
patent: 5278153 (1994-01-01), Biller
patent: 5658889 (1997-08-01), Gruber et al.
patent: 6054587 (2000-04-01), Reddy et al.
patent: 6110903 (2000-08-01), Kasibhatla et al.
patent: 6284748 (2001-09-01), Dang et al.
patent: 6294672 (2001-09-01), Reddy et al.
patent: 6312662 (2001-11-01), Erion et al.
patent: 6399782 (2002-06-01), Kasibhatla et al.
patent: 6489476 (2002-12-01), Dang et al.
patent: 0 427 799 (1994-11-01), None
patent: 0 632 048 (1995-01-01), None
patent: WO 90/08155 (1990-07-01), None
patent: WO 90/10636 (1990-09-01), None
patent: WO 91/19721 (1991-12-01), None
patent: WO 95/07920 (1995-03-01), None
patent: WO 98/39342 (1998-09-01), None
patent: WO 98/39343 (1998-09-01), None
patent: WO 98/39344 (1998-09-01), None
patent: WO 99/47549 (1999-09-01), None
patent: WO 00/14095 (2000-03-01), None
patent: WO 00/38666 (2000-07-01), None
patent: WO 00/52015 (2000-09-01), None
patent: WO 2001089457 (2001-11-01), None
Shan, Daxian, et al, J. Pharmaceutical Sci., 1997, 86, pp. 765-767.
Hawley, Gessner, “The Condensed Chemical Dictonary”, 1977, Van Nostrand, New York, p. 25.
Stedman's (Medical Dictionary, 26thEd.), Williams & Wilkins, Baltimore, 1995, p. 733.
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, p. 596.
Sanchez, J.P. et al, J. Med. Chem, vol. 35, 1992, pp. 1764-1773.
Bundgaard, H. et al, J. Med. Chem., vol. 30, 1987, pp. 454-455.
Krecmerova, Marcela; Holy, Antonin, Collection of Czechoslovak Chemical Communications, 60(4), 659-69 (English) 1995.
Huang, Weisheng; Yuan, Chengye Synthesis (4), 511-13 (English) 1996.
Shaw, J.P et al, Pharm. Res., vol. 14, 1997, 1824-1829.
Alexander, et al., “Preparation or 9-(2-Phosphonomethoxyethyl)adenine Esters as Potential Prodrugs,”Collect. Czech. Chem. Commun., 59:1853-1869 (1994).
Athmani, et al., “Azoles. Part 9.1Synthesis of Derivatives of Thieno[2,3-d]thiazole, 4H-Pyrrolo-[2.3-d]thiazole, 2H-Pyrazolo[3,4-d]thiazole from Thiazolidine-2,4-dione.”J. Chem. Soc., Perkin Trans. 1, 973-977 (1992).
Barluenga, et al., “Substituted Organolithium Compounds. New Reagents for Synthesis,”J. Org. Chem., 44(26):4798-4801 (1979).
Benzaria, et al. “Synthesis in vitro Antiviral Evaluation, and Stability Studies of Bis(S-acyl-2-thioethyl) Ester Derivatives of 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA) as Potential PMEA Prodrugs with improved Oral Bioavailability,”J. Med. Chem., 39:4958-4965 (1996).
Bhongle, et al., “Expedient and High-Yield Synthesis of Alkylphosphonyl Dichlorides Under Mild, Neutral Conditions: Reaction of Bis(Trimethylsilyl)Alkyl Phosphonates with Oxalyl Chloride/Dimethylformamide,”Synth. Commun., 17(9):1071-1076 (1987).
Brinton, et al., “Characterization of Murine CaraparuBunyavirusLiver Infection and Immunomodulator-Mediated Antiviral Protection,”Antiviral Res., 20:155-171 (1992).
Campagne, et al., “Synthesis of Mixed Phosphonate Diester Analogues of Dipeptides using BOP or PyBOP Reagents,”Tetrahedron Lett., 34:6743-6744 (1993).
Campbell, et al., “The Synthesis cf Phosphonate Esters, an Extension of the Mitsunobu Reaction,”J. Org. Chem., 57:6331-6335 (1992).
Canas, et al., “Regioselective Ring Opening of Chiral Epoxyalcohols by Primary Amines,”Tetrahedron Lett., 32:6931-6934 (1991).
Casara, et al., “Synthesis of Acid Stable 5′-O-Fluoromethyl Phosphonates of Nucleosides. Evaluation as Inhibitors of Reverse Transcriptase,”Bioorg. Med. Chem. Lett., 2:145-148 (1992).
Claus, et al., “Mechanism of the Acute Action of Insulin On Hepatic Gluconeogenesis,”Mechanisms of Insulin Action, pp. 305-321, EIsevier Science, (1992).
Commercon, et al., “Diastereoselective Chlorocyclofunctionalization of N-allylic Trichloroacetamides: Synthesis of an Analogue and Potential Precurser of RP49532,”Tetrahedron Lett., 31:3871-3874 (1990).
Corey, et al., “Enantioselective and Practical Synthesis of R- and S-Fluoxetines,”Tetrahedron Lett., 30:5207-5210 (1989).
Curran, Thermolysis of Bis[2—[(trimethylsilyl)oxy]prop-2-yI] fuxoran (TOP-furoxan). The First Practical Method for Intermolecular Cycloaddition of an in Situ Nitrile Oxide with 1,2-Di and Trisubstituted Olefins,J. Am Chem. Soc., 107:6023-6028 (1985).
De Lombaert, et al., “N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11). Inhibitors,”J. Med. Chem., 37:498-511 (1994).
Dickson, et al., “Orally Active Squalene Synthase Inhibitors: Bis(acyloxy) Prodrugs of the α-Phosphonosulfonic Acid Moiety,”J. Med. Chem., 39:661-664 (1996).
Egron, et al., “Synthesis and Anti-HIV Activity of Some S-Acyl-2-Thioethyl (SATE) Phosphoramidate Derivatives of 3′-Azido-2′,3′-Dideoxythymidine,”Nucleosides and Nucleotides, 18:981-982 (1999).
Elhaddadi, et al., “A Convenient Synthesis of Alkyl and Dialkyl 1-Benzyloxyamino Alkyl Phosphonates and Phosphinates,”Phosphorus, Sulfur and Silicon, 54(1-4):143-150 (1990).
Farquhar, et al., “Biologically Reversible Phosphate-Protective Groups,”J. Pharm. Sci., 72:324-325 (1983).
Ferres, H., “Pro-Drugs of β-Lactam Antibiotics,”Drugs of Today, 19:499-538 (1983).
Folsom, et al., “Relation of Carotid artery Wall Thickness to Diabetes Mellitus, Fasting Glucose and Insulin, Body Size, and Physical Activity,”Stroke, 25:66-73 (1994).
Freed, et al., “Evidence for Acyloxymethyl Esters of Pyrimidine 5′-Deoxyribonucleotides as Extracellular Sources of Active 5′-Deoxyribonucleotides in Cultured CeIls,”Biochem. Pharmacol., 38:3193-3198 (1989).
Haddad, et al., “Stereocontrolled Reductive Amination of 3-Hydroxy Ketones,”Tetrahedron Lett., 38:5981-5984 (1997).
Hoffmann, M., “A Simple, Efficient Synthesis of Dibenzyl and Di-p-nitroben 1-Hydroxyalkanephosphonates,”Synthesis, pp. 62-64 (1988).
Hori, et al., “Palladium (lI)-Catalyzed Asymmetric 1,3-Dipolar Cycloaddition of Nitrones to 3-Alkenoyl-1,3-oxazodilin2-ones,”J. Org. Chem., 64:5017-5023 (1999).
Howard, G. et al., “Insulin Sensitivity and Atherosclerosis,”Circulation, 93:1809-1817 (1996).
Iyer, et al., “Synthesis of Acyloxyalkyl Acylphosphonates as Potential Prodrugs of the Antiviral, Trisodium Phosphonoformate (Foscarnet Sodium),”Tetrahedron Lett., 30:7141-7144 (1989).
Khamnei, et al., “Neighboring Group Catalysis in the Design of Nucleotide Prodrugs,”J. Med. Chem., 39:4109-4115 (1996).
Colen, “Complete Regio- and Stereospecificity in the Lewis Acid Catalyzed Diels-Alder Reactions of (Z) 2-Methoxy-1(phenolthio)-1,3-butadienes. Conversion of the CS Configuration of an Adduct to the CC Configuration at the Allylic Position by a [2,3] Sigmatropic Rearrangement,”J. Org. Chem.47:4005-4008 (1982).
Martin, et al., “Synthesis and Antiviral Activity of Various Esters of 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine,”J. Pharm.Sci., 76(2):180-184 (1987).
Maryanoff, “Stereoselective Synthesis and Biological Activity of β- and α-D-Arabinose 1,5-Diphosphate: Analogues of a Potent Metabolic Regulator,”J. Am. Chem. Soc., 106:7851-7853 (1984).
McGuigan, et al., “Synthesis and Anti-HIV Activity of Some Haloalkyl Phosphoramidate Derivatives of 3′-Azido-3′-Deoxythymidine (AZT): Potent Activity of the Trichloroethyl Methoxyalaninyl Compound,”Ant

Affiliated with

Also associated with

Rating

Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3399742